glycerophosphoinositol 4,5-bisphosphate has been researched along with Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Behr, E; Bendahhou, S; Cobo, AM; Donaldson, MR; Escolar, DM; Fu, YH; Jensen, JL; Mozaffar, T; Pereira, S; Poza, JJ; Ptácek, LJ; Suarez, WA; Szepetowski, P; Tawil, R; Tristani-Firouzi, M; Wagstaff, J | 1 |
Birk, OS; Elbedour, K; Hershkowitz, R; Landau, D; Manor, E; Narkis, G; Ofir, R; Volokita, M | 1 |
Bevers, EM; Comfurius, P; Schlegel, RA; Schroit, AJ; Sims, PJ; Smeets, EF; Weiss, HJ; Wiedmer, T; Williamson, P; Zhao, J; Zwaal, RF | 1 |
3 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Syndrome
Article | Year |
---|---|
PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome.
Topics: Abnormalities, Multiple; Arrhythmias, Cardiac; Binding Sites; Female; Genetic Predisposition to Disease; Humans; Male; Muscle Weakness; Mutation; Paralysis; Pedigree; Phenotype; Phosphatidylinositol 4,5-Diphosphate; Potassium Channels, Inwardly Rectifying; Syndrome | 2003 |
Lethal contractural syndrome type 3 (LCCS3) is caused by a mutation in PIP5K1C, which encodes PIPKI gamma of the phophatidylinsitol pathway.
Topics: Alleles; Amino Acid Sequence; Amino Acid Substitution; Arthrogryposis; Asparagine; Aspartic Acid; Chromosomes, Human, Pair 19; Female; Homozygote; Humans; Male; Molecular Sequence Data; Mutation; Pedigree; Phosphatidylinositol 4,5-Diphosphate; Phosphotransferases (Alcohol Group Acceptor); Syndrome | 2007 |
The complex of phosphatidylinositol 4,5-bisphosphate and calcium ions is not responsible for Ca2+-induced loss of phospholipid asymmetry in the human erythrocyte: a study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling.
Topics: 4-Chloro-7-nitrobenzofurazan; Calcium; Erythrocyte Membrane; Erythrocytes; Hemophilia A; Humans; In Vitro Techniques; Kinetics; Lipid Bilayers; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phospholipids; Reference Values; Syndrome; Thromboplastin | 1995 |